Currently, there are 45.10M common shares owned by the public and among those 41.17M shares have been available to trade.
The company’s stock has a 5-day price change of -14.61% and 34.52% over the past three months. CKPT shares are trading 48.03% year to date (YTD), with the 12-month market performance up to 3.99% higher. It has a 12-month low price of $1.36 and touched a high of $4.50 over the same period. CKPT has an average intraday trading volume of 863.09K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -12.66%, -2.01%, and 41.20% respectively.
Institutional ownership of Checkpoint Therapeutics Inc (NASDAQ: CKPT) shares accounts for 15.76% of the company’s 45.10M shares outstanding.
It has a market capitalization of $159.88M and a beta (3y monthly) value of 1.32. The earnings-per-share (ttm) stands at -$1.44. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.65% over the week and 8.46% over the month.
Earnings per share for the fiscal year are expected to increase by 72.24%, and 63.64% over the next financial year.
Looking at the support for the CKPT, a number of firms have released research notes about the stock. B. Riley Securities stated their Buy rating for the stock in a research note on July 14, 2022, with the firm’s price target at $7. B. Riley Securities coverage for the Checkpoint Therapeutics Inc (CKPT) stock in a research note released on June 09, 2021 offered a Buy rating with a price target of $18. H.C. Wainwright on their part issued Buy rating on December 08, 2017.
